| Symbol | GBLX |
|---|---|
| Name | GB SCIENCES, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 89148 United States NV 205 W. Russell Road Suite 240 |
| Telephone | (866) 721-0297 |
| Fax | — |
| — | |
| Website | http://www.gbsciences.com |
| Incorporation | US |
| Incorporated On | 2018 |
| Employees | — |
| Fiscal Year | 3/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Assurance Dimensions Inc; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001165320 |
| Description | GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market. Additional info from OTC: |
No news found.